Article
27 May 2024
Infringing Here, There Or Everywhere: Extraterritorial Damages And Infringement
AUTHORS CONTENT
Article
08 Sep 2023
Podcast: August 2023 - Last Month At The Federal Circuit Podcast Series
Article
17 Mar 2022
Ex Parte Reexamination Scheme Did Not Preclude Review Of Director's Decision To Vacate Reexamination Proceedings Based On IPR Estoppel
Article
18 Nov 2021
CosmoKey Gets A Duo-Over – Federal Circuit Panel Reverses Finding Of Ineligibility
Article
01 Nov 2021
Design Patent Claims Limited To Recited Article Of Manufacture
Article
24 Sep 2021
Federal Circuit Denies Mandamus Petition, Confirming Non-Appealability Of Institution Decisions Despite Parties' Agreement To First Arbitrate Patent Validity
Article
30 Aug 2021
Extrinsic Evidence Cannot Alter Meaning Of Claim Term Clearly Set Forth In Intrinsic
Article
03 Aug 2021
Clarifying Pleading Requirements For Patent Cases
Article
07 Mar 2021
Issue Preclusion Can Apply To Prior Inter Partes Reexamination Determinations
Article
13 Jan 2020
Pending Supreme Court Petition—Athena's Five Reasons The Supreme Court Should Grant Certiorari In Athena Diagnostics v. Mayo Collaborative Services
Article
12 Dec 2019
Pending Supreme Court Petition—A New Battle Over 35 U.S.C. § 101: Hikma Pharms. USA Inc. v. Vanda Pharms. Inc.
Article
26 Nov 2019
Derivation Proceedings
Article
23 Oct 2019
Federal Circuit Finds Method Of Manufacturing Patent Ineligible
Article
15 Oct 2019
Claim Language Could Limit Design Patent Where Specific Article Of Manufacture Not Shown In Figures
Article
14 Oct 2019
IPR Petitioner's Post-Institution Theories Differing From Those Raised In Petition May Be Disregarded
Article
04 Oct 2019
State Sovereignty Does Not Grant State The Right To Sue In Improper Venue
Article
05 Sep 2019
"Substantially Equivalent" Method Of Obtaining Dissolution Profile Meets Written Description Requirement
Article
29 Aug 2019
Federal Circuit Required Resolution Of Claim Construction Dispute Before Ruling On Patent Eligibility At Rule 12(c) Stage
Article
28 Aug 2019
The Federal Circuit Adopts A Liberal, Notice-Based Interpretation Of The Relation Back Doctrine Under Rule 15(c)
Article
18 Jul 2019
Federal Circuit Says Teva's Planned Parkinson's Patch Infringes UCB Patent Under Doctrine Of Equivalents